NASP and SPAARx Merge to Create a Unified Specialty Pharmacy Association
NASP/SPAARx merger creates one, unified voice representing the fastest growing segments in the pharmacy and health care industries.
NASP/SPAARx merger creates one, unified voice representing the fastest growing segments in the pharmacy and health care industries.
The
“Merging the two organizations allows us to combine our leadership and focus on providing services for professionals and other stakeholders that will support the future of our industry,” Lawrence Irene, CEO of Armada, the founder of SPAARx, said. “This opportunity benefits everyone in our industry, allowing us to shine a spotlight on the increasingly important role specialty plays in health care.”
The new association is built on a core mission of providing advanced training in specialty and offering opportunities to build collaboration with the goal of improving patient outcomes. The leadership, representing thought leaders from all major stakeholders including specialty pharmacies, payers, manufacturers, group purchasing organizations and others, initially focuses their attention on building a dynamic strategic plan to address challenges and build opportunities in the specialty market.
“This is a historic moment in our industry—one in which our two organizations come together, recognizing the unique strengths each has contributed to specialty pharmacy and the pharmacy industry as a whole, to develop a strong, unified voice representing all specialty stakeholders,” Gary M. Cohen, BSPharm, RPh, CSP, NASP CEO said.
NASP and SPAARx will integrate their current Board of Directors, committees and members to develop a broad membership and volunteer-based association poised to lead in the pharmacy industry.
Visit
SOURCE: NASP
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Effectively Managing Immunizations in the Long-Term Care SettingSeptember 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet DevelopmentSeptember 18th 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
